Virtual Proteins has recently started the first software pilot project with Prof Ab Osterhaus of Erasmus MC Rotterdam and the WHO National Influenza Center of the Netherlands.

Renowned researchers at Erasmus MC will test the Virtual Proteins MicroLab prototype product in the area of anti-viral drug development. They will help Virtual Proteins to develop and test the MicroLab in a fundamental research environment, using Desktop Virtual Reality technology to simulate and analyze the behaviour of virusses on molecular level.